This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2002 Sep 1;7(17):896-7.

doi: 10.1016/s1359-6446(02)02414-5.

Mistletoe lectins: telomerase inhibitors in alternative cancer therapy

PMID: 12546929
DOI: 10.1016/s1359-6446(02)02414-5

Mistletoe lectins: telomerase inhibitors in alternative cancer therapy

Shi-Sheng Li. Drug Discov Today. 2002.

. 2002 Sep 1;7(17):896-7.

doi: 10.1016/s1359-6446(02)02414-5.

Author

PMID: 12546929
DOI: 10.1016/s1359-6446(02)02414-5

No abstract available

PubMed Disclaimer

Comment in

Current understanding of mistletoe lectins.
Schumacher U, Valentiner U. Schumacher U, et al. Drug Discov Today. 2003 Jan 1;8(1):17. doi: 10.1016/s1359-6446(02)02548-5. Drug Discov Today. 2003. PMID: 12546982 No abstract available.

Similar articles

[Ingredients of mistletoe (Viscum album L.) as potential drugs].
Franz H. Franz H. Pharmazie. 1985 Feb;40(2):97-104. Pharmazie. 1985. PMID: 3889937 German. No abstract available.
Evaluating unconventional therapies.
Hajto T, Saller R. Hajto T, et al. CMAJ. 1998 Oct 6;159(7):759; author reply 759, 761. CMAJ. 1998. PMID: 9805018 Free PMC article. No abstract available.
Molecular characterization of the recombinant A-chain of a type II ribosome-inactivating protein (RIP) from Viscum album coloratum and structural basis on its ribosome-inactivating activity and the sugar-binding properties of the B-chain.
Ye W, Nanga RP, Kang CB, Song JH, Song SK, Yoon HS. Ye W, et al. J Biochem Mol Biol. 2006 Sep 30;39(5):560-70. doi: 10.5483/bmbrep.2006.39.5.560. J Biochem Mol Biol. 2006. PMID: 17002877
Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
Mengs U, Göthel D, Leng-Peschlow E. Mengs U, et al. Anticancer Res. 2002 May-Jun;22(3):1399-407. Anticancer Res. 2002. PMID: 12168816 Review.
Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
Stein GM, Stettin A, Schultze J, Berg PA. Stein GM, et al. Anticancer Drugs. 1997 Apr;8 Suppl 1:S57-9. doi: 10.1097/00001813-199704001-00013. Anticancer Drugs. 1997. PMID: 9179370 Review.

See all similar articles

Cited by

Quality Evaluation of Taxilli Herba from Different Hosts Based on Simultaneous Determination of Multiple Bioactive Constituents Combined with Multivariate Statistical Analysis.
Wu N, Li L, Cai ZC, Yuan JH, Wang WX, Yin SX, Liu SJ, Wei LF, Mei YQ, Chen CH, Liu XH, Zou LS, Li J. Wu N, et al. Molecules. 2021 Dec 10;26(24):7490. doi: 10.3390/molecules26247490. Molecules. 2021. PMID: 34946568 Free PMC article.
Anti-inflammatory effects of oleanolic acid on LPS-induced inflammation in vitro and in vivo.
Lee W, Yang EJ, Ku SK, Song KS, Bae JS. Lee W, et al. Inflammation. 2013 Feb;36(1):94-102. doi: 10.1007/s10753-012-9523-9. Inflammation. 2013. PMID: 22875543
Down-regulation of some miRNAs by degrading their precursors contributes to anti-cancer effect of mistletoe lectin-I.
Li LN, Zhang HD, Zhi R, Yuan SJ. Li LN, et al. Br J Pharmacol. 2011 Jan;162(2):349-64. doi: 10.1111/j.1476-5381.2010.01042.x. Br J Pharmacol. 2011. PMID: 20955366 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information